PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Nizatidine - Acid suppression (Adults)
PAD Profile : Nizatidine - Acid suppression (Adults)
Keywords :
GORD, gastro-oesophageal reflux disease, indigestion, gastric ulcers, stomach ulcers, dyspepsia
Traffic Light Status
Status 1 of 1.
Status :
Green (see narrative)
Important
Preferred
Formulations :
- Capsules
Important Information :
For use where a PPI is not suitable and an H2RA is indicated.
For doses of 300mg, please prescribe 2x150mg as this is considerably more cost effective.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Esomeprazole
- Ranitidine hydrochloride
- Lansoprazole
- Omeprazole
- Pantoprazole
- Rabeprazole sodium
- Cimetidine
- Famotidine
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
05 June 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Nizatidine can be prescribed, for use only in situations where:
- PPIs are not suitable AND
- H2As are indicated and necessary.
if Nizatidine 300mg is required prescribe as multiples of Nizatidine 150mg capsules as significantly more cost effective
Associated BNF Codes
01. Gastro-Intestinal System
01.03.01. H2-receptor antagonists